| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 6 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Japan | 2 | |
| #4 | United States | 2 | |
| #5 | Canada | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Specific use of cosmetics | |
| #4 | Heterocyclic compounds | |
| #5 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Goldberg Dennis I | 13 |
| #2 | Rowe W Bruce | 5 |
| #3 | Mark David A | 3 |
| #4 | Pace Gary | 2 |
| #5 | Baxley L Reade | 1 |
| #6 | Lin Xiaofeng | 1 |
| #7 | Sun Chong-Son | 1 |
| #8 | Rossiter Gordon J | 1 |
| #9 | Wilson Daniel M | 1 |
| #10 | Madsen David C | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US5869679A | Methods for preparing l-2-oxothiazolidine-4-carboxylate and its carboxylic acid | |
| AU6060694A | Method for treating acquired immune deficiency syndrome | |
| AU5040493A | Method for treating systemic inflammatory response syndrome | |
| EP0535390A1 | The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a medicament for treating latent HIV infection | |
| EP0715853A1 | Use of glutathione esters for the treatment of pulmonary diseases |